Ate G J van der Zee

Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions.

Steven J Skates, Yinhua Yu, R. Bast, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical potential of inhibitors of survival pathways and activators of apoptotic pathways in treatment of cervical cancer: changing the apoptotic balance.

Elisabeth G E de Vries, A. V. D. Van Der Zee, E. D. de Vries, 2005, The Lancet. Oncology.

Chip‐LC‐MS for label‐free profiling of human serum

Frank Suits, Peter Horvatovich, Rainer Bischoff, 2007, Electrophoresis.

The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis.

Ignace Vergote, Andreas Scorilas, Marco Massobrio, 2003, Cancer research.

Detecting cervical cancer by quantitative promoter hypermethylation assay on cervical scrapings: a feasibility study.

Yoram Cohen, David Sidransky, H. Boezen, 2004, Molecular cancer research : MCR.

Combining multiple serum tumor markers improves detection of stage I epithelial ovarian cancer.

Daniel W Chan, Yinhua Yu, R. Bast, 2007, Gynecologic oncology.

Distinguishing benign and malignant pelvic masses: the value of different diagnostic methods in everyday clinical practice.

A. V. D. Van Der Zee, W. Sluiter, P. Willemse, 2008, European journal of obstetrics, gynecology, and reproductive biology.